Foreign-Trade Zone (FTZ) 46-Cincinnati, Ohio; Notification of Proposed Production Activity; Patheon Pharmaceuticals Inc. (Pharmaceutical Products), Cincinnati, Ohio, 7394 [2023-02264]

Download as PDF 7394 Notices Federal Register Vol. 88, No. 23 Friday, February 3, 2023 This section of the FEDERAL REGISTER contains documents other than rules or proposed rules that are applicable to the public. Notices of hearings and investigations, committee meetings, agency decisions and rulings, delegations of authority, filing of petitions and applications and agency statements of organization and functions are examples of documents appearing in this section. DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–10–2023] lotter on DSK11XQN23PROD with NOTICES1 Foreign-Trade Zone (FTZ) 148— Knoxville, Tennessee;Notification of Proposed Production Activity;CoLinx, LLC(Wheel Hub-Bearing Assemblies);Crossville, Tennessee CoLinx, LLC submitted a notification of proposed production activity to the FTZ Board (the Board) for its facilities in Crossville, Tennessee within FTZ 148. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on January 27, 2023. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/ component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed finished product(s) and material(s)/component(s) would be added to the production authority that the Board previously approved for the operation, as reflected on the Board’s website. The proposed finished product is wheel hub-bearing assemblies (duty rate 9%). The proposed foreign-status materials and components include: wheel hubs; steel bearing spacers; vulcanized rubber bearing seals; polyethylene shipping caps for bearing retention; and, tapered roller bearings (duty rate ranges from duty-free to 5.8%). The request indicates that the materials/components are subject to duties under Section 301 of the Trade Act of 1974 (Section 301), depending on the country of origin. The applicable Section 301 decisions require VerDate Sep<11>2014 17:51 Feb 02, 2023 Jkt 259001 subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is March 15, 2023. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov. Dated: January 31, 2023. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2023–02311 Filed 2–2–23; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE The proposed foreign-status materials and components include active pharmaceutical ingredient Eluxadoline and mannitol (duty rates, 6.5% and 4.6%, respectively). The request indicates that the materials/components are subject to duties under Section 301 of the Trade Act of 1974 (Section 301), depending on the country of origin. The applicable Section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is March 15, 2023. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Diane Finver at Diane.Finver@trade.gov. Dated: January 30, 2023. Elizabeth Whiteman, Acting Executive Secretary. Foreign-Trade Zones Board [B–9–2023] [FR Doc. 2023–02264 Filed 2–2–23; 8:45 am] Foreign-Trade Zone (FTZ) 46— Cincinnati, Ohio; Notification of Proposed Production Activity; Patheon Pharmaceuticals Inc. (Pharmaceutical Products), Cincinnati, Ohio Patheon Pharmaceuticals Inc. (Patheon) submitted a notification of proposed production activity to the FTZ Board (the Board) for its facilities in Cincinnati, Ohio, within Subzone 46K. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on January 27, 2023. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/ component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed finished product is anti-diarrheal drug (active pharmaceutical ingredient Eluxadoline) packaged into finished dosage (duty free). PO 00000 Frm 00001 Fmt 4703 Sfmt 4703 BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Bureau of Industry and Security In the Matter of: Michael Cox, 1513 E Muir Avenue, Hazel Park, MI 48030– 2671; Order Denying Export Privileges On May 18, 2021, in the U.S. District Court for the Western District of Pennsylvania, Michael Cox (‘‘Cox’’) was convicted of violating 18 U.S.C. 371. Specifically, Cox was convicted of conspiring to export defense articles, specifically Night Sighting Equipment, to the Ukraine without the required licenses. As a result of his conviction, the Court sentenced Cox to 32 months of confinement, three years of supervised release and $100 special assessment. Pursuant to Section 1760(e) of the Export Control Reform Act (‘‘ECRA’’),1 the export privileges of any person who has been convicted of certain offenses, including, but not limited to, 18 U.S.C. 1 ECRA was enacted on August 13, 2018, as part of the John S. McCain National Defense Authorization Act for Fiscal Year 2019, and as amended is codified at 50 U.S.C. 4801–4852. E:\FR\FM\03FEN1.SGM 03FEN1

Agencies

[Federal Register Volume 88, Number 23 (Friday, February 3, 2023)]
[Notices]
[Page 7394]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02264]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-9-2023]


Foreign-Trade Zone (FTZ) 46--Cincinnati, Ohio; Notification of 
Proposed Production Activity; Patheon Pharmaceuticals Inc. 
(Pharmaceutical Products), Cincinnati, Ohio

    Patheon Pharmaceuticals Inc. (Patheon) submitted a notification of 
proposed production activity to the FTZ Board (the Board) for its 
facilities in Cincinnati, Ohio, within Subzone 46K. The notification 
conforming to the requirements of the Board's regulations (15 CFR 
400.22) was received on January 27, 2023.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz.
    The proposed finished product is anti-diarrheal drug (active 
pharmaceutical ingredient Eluxadoline) packaged into finished dosage 
(duty free).
    The proposed foreign-status materials and components include active 
pharmaceutical ingredient Eluxadoline and mannitol (duty rates, 6.5% 
and 4.6%, respectively). The request indicates that the materials/
components are subject to duties under Section 301 of the Trade Act of 
1974 (Section 301), depending on the country of origin. The applicable 
Section 301 decisions require subject merchandise to be admitted to 
FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is March 15, 2023.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: January 30, 2023.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2023-02264 Filed 2-2-23; 8:45 am]
BILLING CODE 3510-DS-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.